skip a week of tirzepatide Can You Tirzepatide? Safety & Clinical Guidance β PlexusDx Weekly dilemmaβ¦ π€ππ₯¬, Option A:
Description
Retatrutide is an investigational triple agonist that targets GIP, GLP-1, and glucagon receptors, while Ozempic is semaglutide, a GLP-1 receptor agonist already approved for type 2 diabetes
HPLC-verified triple agonist (GLP-1/GIP/Glucagon) for metabolic signaling studies
Once your visit is completed, treatment recommendations are provided promptly

Some care providers are experimenting with their own approaches, like spacing doses out going from weekly to every other week, or keeping patients on a lower maintenance dose instead of stopping completely

We strongly advise against purchasing retatrutide from unregulated online sources